ニュートリゲノミクス市場：製品別、用途別-2025-2030年の世界予測

ニュートリゲノミクス市場は、2023年に6億918万米ドルと評価され、2024年には7億1,529万米ドルに達すると予測され、CAGR 17.53％で成長し、2030年には18億8,763万米ドルに達すると予測されています。

ニュートリゲノミクスは、栄養学とゲノミクスが交差する急成長分野であり、個人の遺伝的差異が、食事が健康に及ぼす影響にどのように影響するかを探り、健康を最適化し病気を予防するために、個人に合わせた食事の推奨を提供します。ニュートリゲノミクスの必要性は、肥満、糖尿病、心臓病などの世界の健康課題と闘うために、個別化された栄養ソリューションへの需要が高まっていることから生じています。最終用途は健康・ウェルネス分野、医薬品、機能性食品産業など多岐にわたる。市場成長の原動力は、ゲノム研究の進展、個別化健康に対する消費者の意識の高まり、遺伝子検査技術の進歩です。さらに、慢性的な生活習慣病の増加は、個別化された栄養に対する需要を強調し、ニュートリゲノミクスが拡大する大きな機会を生み出しています。企業は、ゲノミクス・データの可能性を活用し、新製品やサービスを開発するために、研究協力や戦略的パートナーシップに投資することが奨励されています。とはいえ、倫理的な懸念、遺伝子検査にかかる高額な費用、規制上のハードル、消費者の理解不足といった課題が、市場拡大の障壁となっています。透明性の高いデータ実務、費用対効果の高いソリューション、信頼と知識を育むための消費者教育キャンペーンを重視することで、企業がこれらの限界に対処することが極めて重要です。ニュートリゲノミクスにおけるイノベーションのフロンティアは、遺伝子データを分析して実用的な栄養学的洞察を提供するAI主導型ツールの開発、マイクロバイオームとゲノミクスの統合、包括的な健康管理ソリューションの考案にあります。市場はダイナミックで、バイオテクノロジー企業、学術機関、ヘルスケアプロバイダーがパートナーシップを結び、ゲノムの知見を実用的で健康増進につながるアプリケーションに変換しようと努力している協力的なエコシステムが特徴です。企業は、戦略的投資、学際的研究の促進、ビッグデータ解析の活用を通じてこうした動向を活用し、競争力を維持し、ニュートリゲノミクスの導入を推進すべきです。

市場力学：急速に進化するニュートリゲノミクス市場の主要市場インサイトを公開

ニュートリゲノミクス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • ライフスタイルの変化と肥満・糖尿病人口の増加
  • 皮膚科学分野での応用の増加
  • 個別化栄養と食品安全性評価の急増
• 市場抑制要因
  • 熟練医師の不足と治療費の高騰
• 市場機会
  • 研究開発活動への投資の増加
  • 診療におけるAIとMLの統合
• 市場の課題
  • ニュートリゲノミクス分野における規制認可の欠如

ポーターの5つの力：ニュートリゲノミクス市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、ニュートリゲノミクス市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ニュートリゲノミクス市場における外部からの影響の把握

外部マクロ環境要因は、ニュートリゲノミクス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析ニュートリゲノミクス市場における競合情勢の把握

ニュートリゲノミクス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスニュートリゲノミクス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ニュートリゲノミクス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨ニュートリゲノミクス市場における成功への道筋を描く

ニュートリゲノミクス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • ライフスタイルの変化と肥満および糖尿病人口の蔓延
    • 皮膚科での応用が増加
    • パーソナライズされた栄養と食品の安全性評価の急増
  • 抑制要因
    • 熟練した医師の不足と治療費の高騰
  • 機会
    • 研究開発活動への投資の増加
    • ニュートリゲノミクス実践におけるAIとMLの統合
  • 課題
    • ニュートリゲノミクスの分野における規制承認の欠如
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 ニュートリゲノミクス市場：製品別

• 試薬とキット
• サービス

第7章 ニュートリゲノミクス市場：用途別

• がん
• 心血管疾患
• 肥満

第8章 南北アメリカのニュートリゲノミクス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域のニュートリゲノミクス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカのニュートリゲノミクス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• BASF SE
• Cell-Logic Pty Ltd.
• Danone SA
• DSM Nutritional Products AG by Koninklijke DSM N.V.
• Genova Diagnostics Inc.
• Metagenics LLC
• Nutrigenomix Inc.
• Unilever PLC

LIST OF FIGURES

• FIGURE 1. NUTRIGENOMICS MARKET RESEARCH PROCESS
• FIGURE 2. NUTRIGENOMICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL NUTRIGENOMICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL NUTRIGENOMICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL NUTRIGENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS NUTRIGENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS NUTRIGENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC NUTRIGENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC NUTRIGENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA NUTRIGENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NUTRIGENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. NUTRIGENOMICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. NUTRIGENOMICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. NUTRIGENOMICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL NUTRIGENOMICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL NUTRIGENOMICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL NUTRIGENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. NUTRIGENOMICS MARKET DYNAMICS
• TABLE 7. GLOBAL NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL NUTRIGENOMICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL NUTRIGENOMICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL NUTRIGENOMICS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL NUTRIGENOMICS MARKET SIZE, BY OBESITY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. AMERICAS NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS NUTRIGENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 17. ARGENTINA NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 18. ARGENTINA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 19. BRAZIL NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 20. BRAZIL NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. CANADA NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 22. CANADA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. MEXICO NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 24. MEXICO NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 28. ASIA-PACIFIC NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC NUTRIGENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 31. AUSTRALIA NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. AUSTRALIA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. CHINA NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. CHINA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. INDIA NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. INDIA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. INDONESIA NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. INDONESIA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. JAPAN NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. JAPAN NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. MALAYSIA NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. MALAYSIA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. PHILIPPINES NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. PHILIPPINES NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. SINGAPORE NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. SINGAPORE NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. SOUTH KOREA NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. SOUTH KOREA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. TAIWAN NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. TAIWAN NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. THAILAND NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. THAILAND NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. VIETNAM NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. VIETNAM NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. EUROPE, MIDDLE EAST & AFRICA NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA NUTRIGENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 58. DENMARK NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. DENMARK NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. EGYPT NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. EGYPT NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. FINLAND NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. FINLAND NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. FRANCE NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. FRANCE NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. GERMANY NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. GERMANY NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. ISRAEL NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. ISRAEL NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. ITALY NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. ITALY NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. NETHERLANDS NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. NETHERLANDS NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. NIGERIA NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. NIGERIA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. NORWAY NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. NORWAY NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. POLAND NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. POLAND NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. QATAR NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. QATAR NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. RUSSIA NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. RUSSIA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. SAUDI ARABIA NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. SAUDI ARABIA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH AFRICA NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH AFRICA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. SPAIN NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. SPAIN NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. SWEDEN NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. SWEDEN NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. SWITZERLAND NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. SWITZERLAND NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. TURKEY NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. TURKEY NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. UNITED ARAB EMIRATES NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. UNITED ARAB EMIRATES NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. NUTRIGENOMICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 101. NUTRIGENOMICS MARKET, FPNV POSITIONING MATRIX, 2023

The Nutrigenomics Market was valued at USD 609.18 million in 2023, expected to reach USD 715.29 million in 2024, and is projected to grow at a CAGR of 17.53%, to USD 1,887.63 million by 2030.

Nutrigenomics, a burgeoning field at the intersection of nutrition and genomics, explores how individual genetic differences can affect the way diets influence health, providing personalized dietary recommendations to optimize health and prevent disease. The necessity for nutrigenomics arises from the growing demand for personalized nutrition solutions to combat global health challenges such as obesity, diabetes, and heart disease. Applications include personalized diet plans, health supplements, and interventions targeting gene-diet interactions, while end-use spans health and wellness sectors, pharmaceuticals, and functional foods industries. Market growth is driven by advances in genomic research, increasing consumer awareness of personalized health, and technological advancements in genetic testing. Furthermore, the rise in chronic lifestyle diseases underscores the demand for personalized nutrition, creating a significant opportunity for nutrigenomics to expand. Companies are encouraged to invest in research collaborations and strategic partnerships to harness the potential of genomics data and develop new products and services. Nevertheless, challenges such as ethical concerns, high costs of genetic testing, regulatory hurdles, and limited consumer understanding pose barriers to market expansion. It is crucial for businesses to address these limitations by emphasizing transparent data practices, cost-effective solutions, and consumer education campaigns to foster trust and knowledge. The innovation frontier in nutrigenomics lies in the development of AI-driven tools for analyzing genetic data and providing actionable nutritional insights, microbiome integration with genomics, and devising comprehensive health management solutions. The market is dynamic, with a collaborative ecosystem marked by partnerships between biotechnology firms, academic institutions, and healthcare providers striving to translate genomic insights into pragmatic, health-enhancing applications. Companies should capitalize on these trends through strategic investments, fostering multidisciplinary research, and leveraging big data analytics to stay competitive and drive forward the adoption of nutrigenomics.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Nutrigenomics Market

The Nutrigenomics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Changing lifestyle and prevalence of obese and diabetic population
  • Increasing applications in dermatology
  • Surge in personalized nutrition and evaluation of food safety
• Market Restraints
  • Lack of skilled physicians and high cost of treatment
• Market Opportunities
  • Rising investments for R&D activities
  • Integration of AI and ML in nutrigenomics practices
• Market Challenges
  • Lack of regulatory approvals in the field of nutrigenomics

Porter's Five Forces: A Strategic Tool for Navigating the Nutrigenomics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Nutrigenomics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Nutrigenomics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Nutrigenomics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Nutrigenomics Market

A detailed market share analysis in the Nutrigenomics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Nutrigenomics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Nutrigenomics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Nutrigenomics Market

A strategic analysis of the Nutrigenomics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Nutrigenomics Market, highlighting leading vendors and their innovative profiles. These include BASF SE, Cell-Logic Pty Ltd., Danone SA, DSM Nutritional Products AG by Koninklijke DSM N.V., Genova Diagnostics Inc., Metagenics LLC, Nutrigenomix Inc., and Unilever PLC.

Market Segmentation & Coverage

This research report categorizes the Nutrigenomics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Reagents & Kits and Services.
• Based on Application, market is studied across Cancer, Cardiovascular Diseases, and Obesity.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Changing lifestyle and prevalence of obese and diabetic population
    • 5.1.1.2. Increasing applications in dermatology
    • 5.1.1.3. Surge in personalized nutrition and evaluation of food safety
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of skilled physicians and high cost of treatment
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising investments for R&D activities
    • 5.1.3.2. Integration of AI and ML in nutrigenomics practices
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of regulatory approvals in the field of nutrigenomics
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Nutrigenomics Market, by Product

• 6.1. Introduction
• 6.2. Reagents & Kits
• 6.3. Services

7. Nutrigenomics Market, by Application

• 7.1. Introduction
• 7.2. Cancer
• 7.3. Cardiovascular Diseases
• 7.4. Obesity

8. Americas Nutrigenomics Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Nutrigenomics Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Nutrigenomics Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. BASF SE
• 2. Cell-Logic Pty Ltd.
• 3. Danone SA
• 4. DSM Nutritional Products AG by Koninklijke DSM N.V.
• 5. Genova Diagnostics Inc.
• 6. Metagenics LLC
• 7. Nutrigenomix Inc.
• 8. Unilever PLC